SS

Shyama Shankarrao Gitte

Active Director Designated Partner DIN 08715820
DIN 08715820 First appointment Mar 2020 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Shyama Shankarrao Gitte

Data last updated:

Shyama Shankarrao Gitte is a Designated Partner at Stigma Pharmaceuticals Llp (since 2020). The company operates in Business Services.

DIN 08715820
Primary Designation Designated Partner
Industry Business Services
First Appointment 03 Mar 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 Mar 20202020Active

Board colleagues of Shyama Shankarrao Gitte

NameDINCompanyDesignation
Baliram Manikrao Karad08715821Stigma Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Stigma Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Shyama Shankarrao Gitte

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shyama Shankarrao Gitte

Shyama Shankarrao Gitte currently holds 1 directorship: Stigma Pharmaceuticals Llp (Designated Partner, since 03 Mar 2020).

Shyama Shankarrao Gitte was first appointed on 03 Mar 2020 as Designated Partner at Stigma Pharmaceuticals Llp.

The current boards of Shyama Shankarrao Gitte's companies include Baliram Manikrao Karad (Stigma Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available